Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quaker Chemical (KWR) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Quaker Chemical (KWR) over the last 16 years, with Q3 2025 value amounting to $172.0 million.

  • Quaker Chemical's Cash & Equivalents fell 1887.83% to $172.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $172.0 million, marking a year-over-year decrease of 1887.83%. This contributed to the annual value of $188.9 million for FY2024, which is 290.29% down from last year.
  • As of Q3 2025, Quaker Chemical's Cash & Equivalents stood at $172.0 million, which was down 1887.83% from $201.9 million recorded in Q2 2025.
  • Quaker Chemical's 5-year Cash & Equivalents high stood at $212.1 million for Q3 2024, and its period low was $138.9 million during Q3 2022.
  • Its 5-year average for Cash & Equivalents is $179.8 million, with a median of $188.6 million in 2024.
  • Per our database at Business Quant, Quaker Chemical's Cash & Equivalents tumbled by 5484.92% in 2021 and then soared by 4281.56% in 2023.
  • Over the past 5 years, Quaker Chemical's Cash & Equivalents (Quarter) stood at $165.2 million in 2021, then grew by 9.56% to $181.0 million in 2022, then grew by 7.5% to $194.5 million in 2023, then dropped by 2.9% to $188.9 million in 2024, then decreased by 8.92% to $172.0 million in 2025.
  • Its Cash & Equivalents stands at $172.0 million for Q3 2025, versus $201.9 million for Q2 2025 and $186.2 million for Q1 2025.